Transcervical approach for oropharyngeal cancer

Introduction. With the advance of new technology like endoscopic laser and robotic surgery the interest in surgical treatment of the oropharyngeal cancer has been icreasing. However, the possibilities of the traditional techniques are not fully understood.

The study objective is to analyze functional and oncologic results of transcervical approach in surgical treatment of oropharyngeal cancer.

Materials and methods. Since April, 2009 through August, 2016 47 patients with oropharyngeal cancer (34 male and 13 female, aged between 44 and 69 years, mean – 57.6) were operated on through the transcervical approach. All but 2 patients with adenoid cystic (1) and acinic cell (1) had squamous cell carcinoma; 27 tumors originated from the tonsil, 13 – from the base of the tongue, 7 – from the soft palate; 42 (89.4 %) patients had stage III–IV disease. Among them 28 (60 %) were diagnosed with T3–T4 primary tumors; 37 (79 %) patients hadmetastases in lymph nodes. Perioperative tracheostomy was performed in all cases. All patients underwent neck dissection that was bilateral in 3 cases. Modified radical was the most frequent type of neck dissection. The operative approach was enhanced by lip-splitting in 12 patients who had marginal mandibulectomy. Local tissues were used for the reconstruction of the pharyngeal defect in 22 patients. In 25 cases flaps were used: free flaps – in 15, regional flaps with axial blood supply – in 10; thereafter 28 patients received adjuvant radiation with or without chemotherapy. Survival was calculated according to Kaplan–Mayer method.

Results. There was 1 death in early postoperative period with the death rate of 2.1 %. Complications were registered in 13 patients (28 %), 4 of them had multiple complications: total or partial flap necrosis – 6, wound infection – 4, postoperative bleeding – 2, perforative duodenal ulcer – 1, gastric bleeding – 1, neck wound breakdown – 1, pharyngeal wound breakdown – 1. Salivary fistula developed in 3 patients (6.5 %). Tracheostomy tube was removed on postoperative day 6.4 on average. In 43 (91.5 %) cases patients were able to resume oral diet 14 days after the operation on average. The mean follow up was 31.1 (3–101) months. Overall 3-year survival was 54.7 % with 63 % locoregional control. Locoregional failure was the most common cause of death – in 13 patients. Among 26 long-term survivors 25 are able to take food orally, 1 (3.8 %) patient remains to be gastrostomy tube dependent.

Conclusion. Transcervical approach for oropharyngeal cancer is a valuable alternative to mandibulotomy because it characterized by acceptable functional results.

1. Haughey B.H., Hinni M.L., Salassa J.R. et al. Transoral laser microsurgery as pri-mary treatment for advance-stage oropharyngeal cancer: a United States multi-center study. Head Neck 2011;33(12):1683–94. DOI: 10.1002/hed.21669. PMID: 21284056.

2. Wilkie M.D., Upile N.S., Lau A.S. et al. Transoral laser microsurgery for oropha-ryngeal squamous cell carcinoma: a paradigm shift in therapeutic approach. Head Neck 2016;38(8):1263–70. DOI: 10.1002/hed.24432. PMID: 27042800.

3. Ling D.C., Chapman B.V., Kim J. et al. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol 2016;61:41–6. DOI: 10.1016/j.oraloncology.2016.08.004. PMID: 27688103.

4. Dutta S.R., Passi D., Sharma S., Singh P. Transoral robotic surgery: a contemporary cure for future maxillofacial surgery. J Oral Maxillofac Surg Med Pathol 2016;28(4):290–303. DOI: 10.1016/j.ajoms.2016.03.002.

5. Evans M., Jones T.M. Transoral surgery or radiotherapy for oropharyngeal carcinoma – is it either or...? Clin Oncol (R Coll Radiol) 2016;28(7):413–20. DOI: 10.1016/j.clon.2016.02.010. PMID: 26988463.

6. Bastos de Souza T.R., Pinto C.A., da Cunha Mercante A.M. et al. Long-term results of surgical treatment for advanced oropharyngeal squamous cell carcinoma. Head Neck 2014;36(8):1146–54. DOI: 10.1002/hed.23427. PMID: 23897725.

7. Bengtsson M., Korduner M., Campbell V. et al. Mandibular access osteotomy for tu-mor ablation: could a more tissue-preserving technique affect healing outcome? J Oral Maxillofac Surg 2016;74(10): 2085–92. DOI: 10.1016/j.joms.2016.03.036. PMID: 27131029.

8. Dai T.S., Hao S.P., Chang K.P. et al. Complications of mandibulotomy: midline versus paramidline. Otolaryngol Head Neck Surg 2003;128(1):137–41. DOI: 10.1067/mhn.2003.28. PMID: 12574772.

9. Eisen M.D., Weinstein G.S., Chalian A. et al. Morbidity after midline mandibulotomy and radiation therapy. Am J Otolaryngol 2000;21(5):312–7. DOI: 10.1053/ajot.2000.9870. PMID: 11032295.

10. Agrawal A., Wenig B.L. Resection of cancer of the tongue base and tonsil via the transhyoid approach. Laryngoscope 2000;110(11):1802–6. DOI: 10.1097/00005537-200011000-00005. PMID: 11081588.

11. Weber P.C., Johnson J.T., Myers E.N. The suprahyoid approach for squamous cell carcinoma of the base of tongue. Laryngoscope 1992;102(6):637–40. DOI: 10.1288/00005537-199206000-00008. PMID: 1602912.

12. Nasri S., Oh Y., Calcaterra T.C. Transpharyngeal approach to base of tongue tumors: a comparative study. Laryngoscope 1996;106(8):945–50. PMID: 8699906.

13. Roux M., Dassonville O., Ettaiche M. et al. Transoraltranscervical oropharyngectomy without mandibulotomy, associated to fasciocutaneous radial forearm free-flap reconstruction, for oropharyngeal cancer: postoperative course, oncologic and functional results, and prognostic factors. Eur Ann Otorhinolaryngol Head Neck Dis 2017;134(2):71–6. DOI: 10.1016/j.anorl.2016.11.004. PMID: 27914910.

14. Laccourreye O., Benito J., Menard M. et al. Lateral pharyngotomy for selected invasive squamous cell carcinoma of the lateral oropharynx – part I: how. Laryngoscope 2013;123(11):2712–7. PMID: 24325020.

15. Masuda M., Fukushima J., Kadota H. et al. Mandible preserving pull-through oropharyngectomy for advanced oropharyngeal cancer: a pilot study. Auris Nasus Larynx 2011;38(3):392–7. DOI: 10.1016/j.anl.2010.08.010. PMID: 20980111.

16. Tiwari R.M., van Ardenne A., Leemans C.R. et al. Advanced squamous cell carcinoma of the base of the tongue treated with surgery and post-operative radiotherapy. Eur J Surg Oncol 2000;26(6):556–60. DOI: 10.1053/ejso.2000.0946. PMID: 11034805.

17. Díaz-Molina J.P., Rodrigo J.P., Alvarez-Marcos C. et al. Oncological results after surgical treatment of squamous cell cancer of the lateral wall of the oropharynx. Laryngoscope 2011;121(7):1449–54. DOI: 10.1002/lary.21787. PMID: 21647899.

18. Pang P., Li R.W., Shi J.P. et al. A comparison of mandible preservation method and mandibulotomy approach in oral and oropharyngeal cancer: a meta-analysis. Oral Oncol 2016;63:52–60. DOI: 10.1016/j.oraloncology.2016.11.004. PMID: 27939000.

19. Laccourreye O., Benito J., Garcia D. et al. Lateral pharyngotomy for selected invasive squamous cell carcinoma of the lateral oropharynx. Part II: when and why. Laryngoscope 2013;123(11):2718–22. DOI: 10.1002/lary.24246. PMID: 23775844.